Latest Wearable Sensors News

Page 1 of 3
dorsaVi has commercially launched its first wearable capable of analysing movement and delivering feedback directly on-device, while its RRAM chip program moves into fabrication and testing. The progress comes alongside a post-quarter A$3.0 million capital raising, against quarter-end cash of $1.12 million and operating cash outflow of about $996,000.
Sophie Babbage
Sophie Babbage
23 Oct 2026
dorsaVi has secured A$3.0 million to expand its movement-data business for humanoid robotics while advancing its neuromorphic and RRAM chip programs. The raise comes as its first RRAM-CMOS validation chip moves into proprietary memory integration at TSMC.
Sophie Babbage
Sophie Babbage
6 Oct 2026
dorsaVi has confirmed its RRAM memory and neuromorphic IP operate synergistically, projecting up to 10x performance gains for robotics and exoskeletons. The company also finalized its first integrated RRAM-CMOS validation chip design, advancing towards tape-out and commercialisation.
Sophie Babbage
Sophie Babbage
30 July 2026
dorsaVi has unveiled Sensor v6.5, its first wearable sensor that processes and acts on movement data in real time without cloud reliance, marking a key milestone in wearable Physical AI technology.
Sophie Babbage
Sophie Babbage
28 July 2026
dorsaVi has completed the design of its first integrated RRAM-CMOS validation chip, featuring self-checking write-and-verify, compute-in-memory capabilities, and scalable integration on commercial CMOS wafers. The milestone sets the stage for fabrication and commercial engagement in high-value edge AI markets.
Sophie Babbage
Sophie Babbage
18 June 2026
Alterity Therapeutics has clinched FDA agreement on the pivotal Phase 3 trial design for ATH434, targeting Multiple System Atrophy, with the trial set to begin by the end of 2026.
Ada Torres
Ada Torres
9 June 2026
Alterity Therapeutics has showcased compelling Phase 2 data for ATH434 in Multiple System Atrophy, paving the way for a Phase 3 trial with FDA engagement targeted for mid-2026.
Ada Torres
Ada Torres
19 May 2026
dorsaVi has secured a 12-month renewal of its Department of Defense-funded research with Georgia Southern University, advancing real-time gait optimisation to reduce military training injuries and laying groundwork for its exoskeleton and neuromorphic computing strategy.
Sophie Babbage
Sophie Babbage
11 May 2026
dorsaVi has initiated its Ultra-Edge Modular Design program, transitioning from IP development to a manufacturable hardware platform targeting robotics, exoskeletons, and industrial AI with ultra-low power consumption.
Sophie Babbage
Sophie Babbage
6 May 2026
dorsaVi has launched a multi-year partnership with Taiwan’s ITRI and NTU to develop its proprietary RRAM platform at the 22-nm node, complemented by a new advisory board and neuromorphic IP acquisition, positioning the company at the forefront of ultra-edge AI hardware.
Sophie Babbage
Sophie Babbage
30 Apr 2026
dorsaVi is pivoting from wearable sensors to powering next-gen exoskeletons, leveraging its neuromorphic RRAM technology to tap a projected $2 billion market by 2033.
Sophie Babbage
Sophie Babbage
28 Apr 2026
dorsaVi has confirmed that its proprietary RRAM memory technology and neuromorphic IP portfolio work seamlessly together, projecting a tenfold boost in performance for robotics and exoskeleton applications. This breakthrough lays the groundwork for smarter, faster, and more energy-efficient wearable and robotic devices operating at the ultra-edge.
Sophie Babbage
Sophie Babbage
21 Apr 2026

Browse the archive

Full archive